National Institutes of Health
National Cancer Institute
Title: Modeling KSHV latency in vivo
Principal Investigator: Ethel Cesarman, MD PhD
Period of Support09/04/12-06/30/17
Total Direct Costs: $971,890

National Institutes of Health
National Cancer Institute
Title: Molecular Signatures of Lethal and Indolent Prostate Cancer
Principal Investigator: Mark A. Rubin, MD
Period of Support: 07/23/12-05/31/17
Total Direct Costs: $1,655,288

Prostate Cancer Foundation
Mazzone Challenge Award
Title: Interrogation of aberrant DNA repair in sporadic prostate cancer
Principal Investigator: Mark A. Rubin, MD
Period of Support: 08/01/12-07/31/14
Total Direct Costs: $250,000

Prostate Cancer Foundation/ Millenium Pharmaceuticals
Creativity Award
Title: Precision Medicine Sequencing
Principal Investigator: Mark A. Rubin, MD
Period of Support: 08/01/12-07/31/14
Total Direct Costs: $300,000

Prostate Cancer Foundation
SU2C Award
Title: Precision Therapy of Advanced Prostate Cancer
Principal Investigator: Mark A. Rubin, MD
Period of Support: 08/01/12-07/31/15
Total Direct Costs: $377,501

National Institutes of Health
National Cancer Institute (subaward)
Title: Systematic Genetic Characterization of African American Prostate Cancer
Principal Investigator: Mark A. Rubin, MD
Period of Support: 07/15/12-06/30/17
Total Direct Costs: $166,000

Prostate Cancer Foundation
Young Investigator Award
Title: Nano-Targeting Estrogen Receptor regulated Long Non Coding RNA in Prostate
Cancer Progression
Principal Investigator: Dimple Chakravarty, PhD
Period of Support: 03/01/12-02/28/15
Total Direct Costs: $225,000

Sidney Kimmel Cancer Foundation
Kimmel Scholars Award
Title: Function of Fox0 in EGFR-targeted gliomas
Principal Investigator: Jihye Paik, PhD
Period of Support: 07/01/12-06/30/14
Total Direct Costs: $200,000

National Cancer Institute
National Cancer Institute (Subaward)
Title: The Role of Bioactive Lipids in Inflammation and Cancer
Principal Investigator: Timothy Hla, PhD
Period of Support: 06/01/12-05/31/17
Total Direct Costs: $1,567,500

National Institutes of Health
National Heart, Lung, Blood Institute (Subaward)
Title: Personalization of Therapeutic Efficacy and Risk
Principal Investigator: Timothy Hla, PhD
Period of Support: 08/01/12-5/31/17
Total Direct Costs: $420,000

The Methodist Hospital Research Institute
Cancer Pilot Project
Title: Multistage vector-siRNA targeting of lymphoma and multiple myeloma
Principal Investigator: Selina Chen-Kiang, PhD
Period of Support: 08/01/12-07/31/13
Total Direct Costs: $20,000

Leukemia & Lymphoma Society
TAP Correlative Study
Title: A Phase I trial of timed sequential administration of PD0332991 followed by ara-C and Mitoxantrone
Principal Investigator: Selina Chen-Kiang, PhD
Period of Support: 06/12/12-06/11/15
Total Direct Costs: $136,200

Leukemia & Lymphoma Society
Translational Research Grant
Title: Principal Investigator: Dr. Y.Lynn Wang MD PhD
Period of Support: 10/01/12-09/30/15
Total Direct Costs: $540,054

_{Last update: 10/04/12}